Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Web – sheet or filament bases; compositions of bandages; or...
Reexamination Certificate
2011-06-21
2011-06-21
Hui, San-ming (Department: 1628)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Web, sheet or filament bases; compositions of bandages; or...
C514S114000
Reexamination Certificate
active
07964212
ABSTRACT:
The invention provides effervescent composition comprising a bisphosphonate, an acidic compound, an alkaline effervescing component, and optionally an anti-ulcer agent and methods of treating osteoporosis in a mammal using the effervescent compositions.
REFERENCES:
patent: 4393531 (1983-07-01), Gergely et al.
patent: 4462982 (1984-07-01), Samejima et al.
patent: 4621077 (1986-11-01), Rosini et al.
patent: 4687662 (1987-08-01), Schobel
patent: 4710384 (1987-12-01), Rotman
patent: 4942039 (1990-07-01), Duvall et al.
patent: 5178878 (1993-01-01), Wehling et al.
patent: 5270365 (1993-12-01), Gertz et al.
patent: 5348745 (1994-09-01), Daher
patent: 5393531 (1995-02-01), Gerhard et al.
patent: 5415870 (1995-05-01), Gergely et al.
patent: 5480652 (1996-01-01), Bru-Magntez et al.
patent: 5488041 (1996-01-01), Barbier et al.
patent: 5646134 (1997-07-01), Yates
patent: 5709886 (1998-01-01), Bettman et al.
patent: 5853759 (1998-12-01), Katdare et al.
patent: 5994329 (1999-11-01), Daifotis et al.
patent: 6015801 (2000-01-01), Daifotis et al.
patent: 6225294 (2001-05-01), Daifotis et al.
patent: 6284272 (2001-09-01), Chiesi et al.
patent: 6333316 (2001-12-01), Daifotis et al.
patent: 2001/0002395 (2001-05-01), Daifotis
patent: 1127573 (2001-08-01), None
patent: 2153225 (1985-08-01), None
patent: WO 9311774 (1993-06-01), None
patent: WO 9414455 (1994-07-01), None
patent: WO 9641618 (1996-12-01), None
patent: WO 97/44017 (1997-11-01), None
patent: WO 9744017 (1997-11-01), None
patent: WO 01/39724 (2001-06-01), None
patent: WO 139724 (2001-06-01), None
patent: WO 01/52848 (2001-07-01), None
Bull, An lntroduction to Physical Biochemistry, 1964, p. 103.
Goodman et al., The Pharmacological Basis to Therapeutics, Ninth Edition, 1995, p. 51.
Gertz at at, Studies of the Oral Bioavailability of Alendronate, Clinical Pharmacology & Therapeutics, Sep. 1995, pp. 285-298.
2000, Aldrich Handbook of Fine Chemicals and Laboratory Equipment, pp. 436, 1498, and 1505.
Dobrucali et al., Physiological and Morphological Effects of Alendronate on Rabbit Esophageal Epithelium, Am. J. Physiol. Gastrointest Liver Physiol, Sep. 2002, vol. 283(3): pp. G576-G586.
Grattan et al., A Five Way Crossover Human Volunteer Study to Compare the Pharmacokinetics of Paracetamol Following Oral Administration of Two Commercially Available Paracetamol in Combination with Sodium Tablets Containing Paracetamol in Combination with Sodium Bicarbonate or Calcium Carbonate, European J. of Pharmaceutics and Biopharmaceutics, vol. 49 (2000), pp. 225-229.
Beers, “The Merck Manual of Diagnosis and Therpay” (17thED) (1999), pp. 250-254.
IPER PCT/US03/33053.
ISR PCT/US03/33053.
ISR PCT/US03/06576.
U.S. Appl. No. 09/722,589, filed Nov. 28, 2000, applicant Ehrenboefer.
U.S. Appl. No. 09/722,590, filed Nov. 28, 2000, applicant Ehrenhoefer.
Gertz, “Studies of the Oral Bioavailability of Alendronate”, Sep. 1995, p. 288-298, Clinical Pharmacology & Theraputics, vol. 58, No. 3 St. Louis, MO, US.
Aug. 2010, European Search Report (EP 10 01 0775).
Hui San-ming
Neifeld IP Law P.C.
LandOfFree
Effervescent compositions comprising phosphonates and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Effervescent compositions comprising phosphonates and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Effervescent compositions comprising phosphonates and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2713604